King Pharma Sues Sandoz Over Generic EpiPen
EpiPen maker King Pharmaceuticals Inc. has lodged a complaint against Novartis AG's Sandoz Inc. unit, seeking to block the generic-drug maker from making and selling its own version of the epinephrine...To view the full article, register now.
Already a subscriber? Click here to view full article